Campylobacter, from obscurity to celebrity

Clinical Microbiology and Infection

Volumn 10, Issue 10, 2004, Pages 868-876

  Butzler, Jean Paul ^a,b  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b NONE   (Belgium)

Author keywords

Animals; Campylobacter spp.; Food infections; Gastroenteritis; Review

Indexed keywords

BACTERIAL VACCINE; CIPROFLOXACIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARCOBACTER; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD SAMPLING; CAMPYLOBACTER; CLINICAL FEATURE; DIARRHEA; DISEASE TRANSMISSION; FECES ANALYSIS; FEVER; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION RISK; MORBIDITY; MORTALITY; NONHUMAN; PERSONAL HYGIENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIBRIO; WORLD HEALTH ORGANIZATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI;

EID: 6444243531     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00983.x     Document Type: Review

References (114)

1. Escherich T. Beitrage zur Kenntniss der Darmbacterien. III. Ueber das Vorkommen von Vibrionen im Darmcanal und den Stuhlgangen der Sauglinge. (Articles adding to the knowledge of intestinal bacteria. III. On the existence of vibrios in the intestines and feces of babies.) Münchener Med Wochenschrift 1886; 33: 815-817.
2. Kist M. The historical background to campylobacter infection: new aspects. In: Pearson AD, Skirrow MB, Lior H, Rowe B, eds. Campylobacter III. London: Public Health Laboratory Service, 1985; 23-27.
3. McFadyean J, Stockman S. Report of the Departmental Committee appointed by the Board of Agriculture and Fisheries to inquire into Epizootic Abortion. III. Abortion in Sheep. London: HMSO, 1913.
4. Smith T. The etiological relation of Spirilla (V. foetus) to bovine abortion. J Exp Med 1919; 30: 313-323.
5. Smith T, Taylor MS. Some morphological and biological characters of Spirilla (Vibrio foetus n.sp.) associated with disease of fetal membranes in cattle. J Exp Med 1919; 30: 299-311.
6. Stegenga Th, Terpstra JI. Over Vibrio foetus infecties bij het rund en enzootische steriliteit. Tijdschr Diergeneesk 1949; 74: 293-296.
7. Florent A. Les deux Vibrioses génitales de la bête bovine: la vibriose vénérienne, due à V. fœ tus venerialis, et la Vibriose d'origine intestinale due à V. fœtus intestinalis. Proc 16th Int Vet Congr 1959; 2: 489-493.
8. Jones FS, Orcutt M, Little RB. Vibrios (Vibrio jejuni n.sp.) associated with intestinal disorders of cows and calves. J Exp Med 1931; 53: 853-864.
9. Doyle LP. A vibrio associated with swine dysentery. Am J Vet Res 1944; 5: 3-5.
10. Vinzent R, Dumas J, Picard N. Septicémie grave au cours de la grossesse due à un Vibrion. Avortement consécutif. Bull Acad Nat Med Paris 1947; 131: 90-92.
11. Levy AJ. A gastro-enteritis outbreak probably due to a bovine strain of vibrio. J Infect Dis 1946; 18: 243-258.
12. King EO. Human infections with Vibrio fetus and a closely related vibrio. J Infect Dis 1957; 101: 119-128.
13. King EO. The laboratory recognition of Vibrio fetus and a closely related Vibrio isolated from cases of human vibriosis. Ann NY Acad Sci 1962; 98: 700-711.
14. Wheeler WE, Borchers J. Vibrionic enteritis in infants. Am J Dis Child 1961; 101: 60-66.
15. Middelkamp JM, Wolf HA. Infection due to a 'related' vibrio. J Pediatr 1961; 59: 318-321.
16. White WD. Human vibriosis: indigenous case in England. BMJ 1967; 2: 283-287.
17. Darrell JH, Farrell BC, Mulligan RA. Case of human vibriosis. BMJ 1967; 2: 287-289.
18. Sebald M, Véron M. Teneur en bases de l'ADN et classification des vibrions. Ann Inst Pasteur 1963; 105: 897-910.
19. Dekeyser P, Gossuin-Detrain M, Butzler JP, Sternon J. Acute enteritis due to a related vibrio: first positive stool cultures. J Infect Dis 1972; 125: 390-392.
20. Butzler JP, Dekeyser P, Detrain M, Dehaen F. Related vibrio in stools. J Pediatr 1973; 82: 493-495.
21. Butzler JP. Campylobacter, an unrecognised pathogen. PhD Thesis, Free University of Brussels, Belgium 1974.
22. Butzler JP, Dekeyser P, Lafontaine Th. The susceptibility of related vibrios and Vibrio foetus to twelve antibiotics. Antimicrob Agents Chemother 1974; 5: 86-89.
23. Butzler JP. Related vibrios in Africa. Lancet 1978; ii: 858.
24. Skirrow MB. Campylobacter enteritis: a 'new' disease. BMJ 1977; 2: 9-11.
25. Butzler JP, De Boeck M, Goossens H. New selective medium for isolation of Campylobacter jejuni from faecal specimens. Lancet 1983; i: 818.
26. Bolton FJ, Hutchinson DN, Coates D. Blood-free selective medium for isolation of Campylobacter jejuni from feces. J Clin Microbiol 1984; 19: 169-171.
27. Karmali MA, Simor AE, Roscoe M et al. Evaluation of a blood-free, charcoal based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microb 1986; 23: 456-459.
28. Goossens H, De Boeck M, Coignau H et al. Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol 1986; 24: 840-843.
29. Goossens H, Vlaes L, Galand I et al. Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimens. J Clin Microbiol 1989; 27: 1077-1080.
30. Endtz HP, Ruijs GJ, Zwinderman AH et al. Comparison of six media, including a semisolid agar, for the isolation of various Campylobacter species from stool specimens. J Clin Microbiol 1991; 29: 1007-1010.
31. Lauwers S, De Boeck M, Butzler JP. Campylobacter enteritis in Brussels. Lancet 1978; i: 604-605.
32. Severin WPJ. Campylobacter enteritis. Ned T Gen 1978; 122: 499.
33. Lindquist B, Kjellander J, Kosunen T. Campylobacter enteritis in Sweden. BMJ 1978; 1: 303.
34. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr 1979; 94: 527-533.
35. Blaser MJ, Berkowitz ID, Laforce FM et al. Campylobacter enteritis and epidemiological features. Ann Intern Med 1979; 91: 179-185.
36. De Mol P, Bosmans E. Campylobacter enteritis in Central Africa. Lancet 1978; i: 604.
37. Butzler JP, Skirrow MB. Campylobacter enteritis. Clin Gastroenterol 1979; 8: 737-765.
38. Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter jejuni subsp. jejuni on the basis of heat-stable antigens. J Clin Microbiol 1980; 12: 732-737.
39. Lior H, Woodward DL, Edgar JA et al. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol 1982; 15: 761-768.
40. Butzler JP, Glupczynski Y, Goossens H. Campylobacter and Helicobacter infections. Curr Opin Infect Dis 1992; 5: 80-87.
41. Mishu-Allos B. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001 32: 1201-1206.
42. Crushell E, Harty S, Sharif F et al. Enteric Campylobacter: purging its secrets? Pediatr Res 2004; 55: 3-12.
43. Lecuit M, Abachin E, Martin A et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239-248.
44. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteremia in England and Wales, 1981-1991. Epidemiol Infect 1993; 110: 567-573.
45. Goossens H, Henocque G, Kremp J et al. Nosocomial outbreak of Campylobacter jejuni meningitis in newborn infants. Lancet 1986; ii: 146-149.
46. Vandenberg O, Klein A, Souayah H et al. Possible Campylobacter jejuni osteomyelitis in a 14-month-old child. Int J Infect Dis 2003; 7: 164-165.
47. Rhodes KM, Tattersfield AE. Guillain-Barré syndrome associated with Campylobacter infection. BMJ 1982; 285: 173-174.
48. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. BMJ 1984; 288: 1867-1870.
49. Nachamkin I, Mishu-Allos B, Ho TW. Campylobacter jejuni infection and the association with Guillain-Barré syndrome. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 155-178.
50. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.
51. Ang CW, Noordzij PG, de Klerk MA et al. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharide determines antiganglioside specificity in rabbits. Infect Immun 2002; 70: 5081-5085.
52. Gilbert M, Godschalk PC, Karwaski MF et al. Evidence for acquisition of the lipopolysaccharide biosynthesis locus in Campylobacter jejuni GB 11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange. Infect Immun 2004; 72: 1162-1165.
53. Vandamme P, De Ley J. Proposal for a new family, Campylobacteriaceae. Int J Syst Bacteriol 1991; 41: 451-455.
54. Vandamme P, Vancanneyt M, Pot B et al. Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb.nov. and Arcobacter skirrowii sp.nov., an aerotolerant bacterium isolated from veterinary specimens. Int J Syst Bacteriol 1992; 42: 451-455.
55. Vandamme P, Goossens H. Taxonomy of Campylobacter, Arcobacter, and Helicobacter: a review. Zbl Bakteriol 1992; 276: 447-472.
56. Vandamme P. Taxonomy of the family Campylobacteriaceae. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 3-26.
57. Goossens H, Vlaes L, De Boeck M et al. Is 'Campylobacter upsaliensis' an unrecognized cause of human diarrhoea? Lancet 1990; 335: 584-586.
58. Labarca JA, Sturgeon J, Borenstein L et al. Campylobacter upsaliensis: another pathogen for consideration in the United States. Clin Infect Dis 2002; 34: 59-60.
59. Tauxe RV, Patton CM, Edmonds P et al. Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol 1985; 21: 222-225.
60. Skirrow MB. Infection with Campylobacter and Arcobacter. In: Collier L, Balows A, Sussman M, eds. Topley and Wilson's microbiology and microbial infections, 9th edn, Vol. 3. London: Arnold, 1998; 567-580.
61. Lastovica AJ, Engel ME, Blaser MJ et al. Atypical campylobacters and related organisms. In: Blaser MJ, Smith PD, Ravdin JI et al., eds. Infections of the gastrointestinal tract, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2002; 741-761.
62. Lauwers S, Devreker T, Van Etterijck R et al. Isolation of Campylobacter concisus from human faeces. Microb Ecol Health Dis 1991; 4(suppl): S91.
63. Kiehlbauch JA, Brenner DJ, Nicholson MA et al. Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness. J Clin Microbiol 1991; 29: 376-385.
64. Vandamme P, Pugina P, Benzi G et al. Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol 1992; 30: 2335-2337.
65. On SLW, Stacey A, Smyth J et al. Isolation of Arcobacter butzleri from a neonate with bacteraemia. J Infect 1995; 31: 225-227.
66. Dediste A, Aeby A, Ebraert A et al. Arcobacter in stools: clinical features diagnosis and antibiotic susceptibility. In: Lastovica AJ, Newell DG, Lastovica EE, eds. Campylobacter, Helicobacter and related organisms. Cape Town: Institute of Child Health, University of Cape Town, 1998; 436-439.
67. Vandenberg O, Dediste A, Vlaes L et al. Arcobacter species: an unusual intestinal pathogen in childhood [abstract P 36.006]. In: Program and abstracts of the 10th International Congress on Infectious Diseases. Singapore: International Society for Infectious Diseases, 2002, 86.
68. On SL, Jensen TK, Bille-Hansen V et al. Prevalence and diversity of Arcobacter spp. isolated from the internal organs of spontaneous porcine abortions in Denmark. Vet Microbiol 2002; 85: 159-167.
69. Wybo I, Breynaert J, Lindenburg F et al. Isolation of Arcobacter skirrowii from a patient with chronic diarrhea. J Clin Microbiol 2004; 42: 1851-1852.
70. Bolton FJ. Methods for isolation of Campylobacter from humans, animals, food and water. In: The increasing incidence of campylobacteriosis in humans. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001; 87-94.
71. Hindiyeh M, Jense S, Hohmann S et al. Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area. J Clin Microbiol 2000; 38: 3076-3079.
72. Dediste A, Vandenberg O, Vlaes L et al. Evaluation of ProSpecT Microplate Assay for detection of Campylobacter: a routine laboratory perspective. Clin Microbiol Infect 2003; 9: 1085-1090.
73. Kulkarni SP, Lever S, Logan JM et al. Detection of Campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol 2002; 55: 749-753.
74. Lauwers S, Vlaes L, Butzler JP. Campylobacter serotyping and epidemiology. Lancet 1981; i: 158.
75. Frost JA, Oza AN, Thwaites RT, Rowe B. Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat stable antigens. J Clin Microbiol 1998; 36: 335-339.
76. Frost JA, Kramer JM, Gillanders SA. Phage typing of Campylobacter jejuni and Campylobacter coli and its use as an adjunct to serotyping. Epidemiol Infect 1999; 123: 47-55.
77. Newell DG, Frost JA, Duim B et al. New developments in the subtyping of Campylobacter species. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 27-44.
78. Wassenaar TM, Newell DG. Genotyping of Campylobacter spp. Appl Environ Microbiol 2000; 66: 1-9.
79. Svedhem A, Lauwers S, Kaijser B. Diagnostic serology for Campylobacter jejuni infections using the DIG-ELISA principle and a comparison with complement fixation test. In: Butzler JP, ed. Campylobacter infection in man and animals. Boca Raton, FL: CRC Press, 1984; 105-112.
80. Cawthraw SA, Feldman RA, Sayers AR et al. Long-term antibody responses following human infection with Campylobacter jejuni. Clin Exp Immunol 2002; 130: 101-106.
81. Salazar-Lindo E, Sack RB, Chea-Woo E et al. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr 1986; 109: 355-360.
82. Butzler JP, Mégraud F. Campylobacter and Helicobacter pylori. In: Zinner SH, Young LS, Acar JF, Neu HC, eds. Expanding indications for the new macrolides, azalides and streptogramins. New York: Dekker, 1997; 237-249.
83. Endtz HP, Ruijs GJ, Van Klingeren B et al. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicob Chemother 1991; 27: 199-208.
84. Piddock LJ. Quinolone resistance and Campylobacter spp. J Antimicrob Chemother 1995; 36: 891-898.
85. Murphy GS, Echeverria P, Jackson LR et al. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in US troops deployed in Thailand in 1994. Clin Infect Dis 1996; 22: 868-869.
86. Fernandez H. Emergence of antimicrobial resistance in Campylobacter: the consequences for incidence, clinical course, epidemiology and control. In: The increasing incidence of campylobacteriosis in humans. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001; 67-72.
87. Smith KE, Besser JM, Hedberg CW et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340: 1525-1532.
88. Smith KE, Bender JB, Osterholm MT. Antimicrobial resistance in animals and relevance to human infections. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 483-495.
89. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA 1982-2001. Emerg Infect Dis 2002; 8: 1501-1503.
90. McDermott PF, Bodeis SM, English LL et al. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. J Infect Dis 2002; 185: 837-840.
91. Unicomb L, Ferguson J, Riley TV, Collignon P. Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg Infect Dis 2003; 9: 1482-1483.
92. Threlfall EJ. Fluoroquinolone-resistant Campylobacter infections and animal drug use. Int J Infect Dis 2004; 8: 190-192.
93. Friedman CR, Hoekstra RM, Samuel M et al. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in Food Net sites. Clin Infect Dis 2004; 38 suppl 3): S285-S296.
94. Kassenberg HD, Smith KE, Vugia DJ et al. Fluoroquinolone-resistant Campylobacter infections eating outside of the home and foreign travel are risk factors. Clin Infect Dis 2004; 38(suppl 3): S279-S284.
95. Tauxe R. Incidence, trends and source of campylobacteriosis in developed countries: an overview. In: The increasing incidence of campylobacteriosis in humans. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001; 42-43.
96. Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter infection. In: Butzler JP, ed. Campylobacter infection in man and animals. Boca Raton, FL: CRC Press, 1984; 143-162.
97. Skirrow MB. Epidemiology of Campylobacter enteritis. Int J Food Microbiol 1991; 12: 9-16.
98. Butzler JP, Oosterom J. Campylobacter: pathogenicity and significance in foods. Int J Food Microbiol 1991; 12: 1-8.
99. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni - an emerging foodborne pathogen. Emerg Infect Dis 1999; 5: 28-35.
100. Jacobs-Reitsma W. Campylobacter in the food supply. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 467-481.
101. Vellinga A, Van Loock F. The dioxin crisis as experiment to determine poultry-related campylobacter enteritis. Emerg Infect Dis 2002; 8: 19-22.
102. Frost JA, Gillespie JA, O'Brien SJ. Public health implications of Campylobacter outbreaks and microbiological investigations. Epidemiol Infect 2002; 128: 111-118.
103. De Mol P, Brasseur D, Hemelhof W et al. Enteropathogenic agents in children with diarrhoea in rural Zaire. Lancet 1983; i: 516-518.
104. Oberhelman RA, Taylor DN. Campylobacter infections in developing countries. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 139-154.
105. Coker AO, Isokpehi RD, Thomas BN et al. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002; 8: 237-244.
106. Newell DG, Wagenaar JA. Poultry infections and their control at the farm level. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: American Society for Microbiology, 2000; 497-509.
107. Kapperud G. Campylobacter infection. Epidemiology, risk factors and preventive measures. Tidsskr Nor Laegeforen 1994; 114: 795-799.
108. Anonymous. Control and prevention of Campylobacter infections. Suggestions for the design, conduct and analysis of an epidemiological study aimed at identification of risk factors for Campylobacter infections in humans. Geneva: World Health Organization, 1998.
109. Anonymous. The increasing incidence of human campylobacteriosis. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001.
110. Grados O, Bravo N, Black RE, Butzler JP. Pediatric Campylobacter diarrhoea from household exposure to live chickens in Lima, Peru. Bull WHO 1988; 66: 369-374.
111. Ruiz-Palacios GM, Calva JJ, Pickering LK et al. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J Pediatr 1990; 116: 707-713.
112. Scott DA. Vaccines against Campylobacter jejuni. J Infect Dis 1997; 176(suppl 2): S183-S188.
113. Lee LH, Burg E, Baqar S et al. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect Immun 1999; 67: 5799-5805.
114. Parkhill J, Wren BW, Mungall K et al. The genome sequence of the foodborne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403: 66-68.